Dark Forest Capital Management LP purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 7,564 shares of the company’s stock, valued at approximately $210,000.
Other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP grew its holdings in shares of Option Care Health by 157.1% in the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock worth $250,841,000 after purchasing an additional 4,549,164 shares during the last quarter. Massachusetts Financial Services Co. MA bought a new stake in Option Care Health in the 2nd quarter worth $68,003,000. Magnetar Financial LLC increased its position in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after acquiring an additional 1,377,929 shares during the period. Duquesne Family Office LLC raised its stake in shares of Option Care Health by 172.8% during the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after acquiring an additional 1,185,613 shares during the last quarter. Finally, Hood River Capital Management LLC boosted its holdings in shares of Option Care Health by 77.2% during the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after purchasing an additional 753,208 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Option Care Health Trading Down 0.4 %
Shares of OPCH opened at $31.30 on Tuesday. Option Care Health, Inc. has a 1-year low of $26.11 and a 1-year high of $34.63. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The firm’s 50-day moving average price is $31.29 and its 200-day moving average price is $30.40. The firm has a market capitalization of $5.44 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 2.42 and a beta of 1.29.
Insider Activity at Option Care Health
In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on OPCH shares. Barrington Research boosted their price target on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. JMP Securities upped their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday.
View Our Latest Analysis on OPCH
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- Why Are These Companies Considered Blue Chips?
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Stock Splits, Do They Really Impact Investors?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Find and Profitably Trade Stocks at 52-Week Lows
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.